Cargando…

Hsp90表达上调与肺癌细胞化疗耐药的相关性研究

BACKGROUND AND OBJECTIVE: Hsp90 is a major molecular chaperone, which overexpression is involved in oncogenesis, development and drug resistance in many human cancers. The aim of this study is to investigate the relationship between the GGA-induced overexpression of Hsp90 and chemoresistance to Cisp...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999893/
https://www.ncbi.nlm.nih.gov/pubmed/21645448
http://dx.doi.org/10.3779/j.issn.1009-3419.2011.06.02
_version_ 1783331545675726848
collection PubMed
description BACKGROUND AND OBJECTIVE: Hsp90 is a major molecular chaperone, which overexpression is involved in oncogenesis, development and drug resistance in many human cancers. The aim of this study is to investigate the relationship between the GGA-induced overexpression of Hsp90 and chemoresistance to Cisplatin in SPCA-1 and H446 cell line. METHODS: The protein expressions of Hsp90 induced by GGA at different concentrations were analyzed by Immunofluorescence and Western blotting. Cells survival to Cisplatin was determined using the MTT assays. The effect of Hsp90 expression on the drug resistance to Cisplatin in two Cell Lines was analyzed. RESULTS: Compared with the respective control cells, Hsp90 expressions in both experimental cell lines were up-regulated obviously, exhibiting a dose-dependent manner to GGA. MTT assays revealed that the IC(50)s of cisplatin also showed a substantial elevation for the experimental cells of SPCA-1 and H446, and this elevation was also associated with GGA concerntration. CONCLUSION: GGA is effective for the induction of Hsp90 in the SPCA-1 and H446 cell line. Up-regulated Hsp90 is associated with the chemoresistance to Cisplatin in SPCA-1and H446 cells.
format Online
Article
Text
id pubmed-5999893
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-59998932018-07-06 Hsp90表达上调与肺癌细胞化疗耐药的相关性研究 Zhongguo Fei Ai Za Zhi 基础研究 BACKGROUND AND OBJECTIVE: Hsp90 is a major molecular chaperone, which overexpression is involved in oncogenesis, development and drug resistance in many human cancers. The aim of this study is to investigate the relationship between the GGA-induced overexpression of Hsp90 and chemoresistance to Cisplatin in SPCA-1 and H446 cell line. METHODS: The protein expressions of Hsp90 induced by GGA at different concentrations were analyzed by Immunofluorescence and Western blotting. Cells survival to Cisplatin was determined using the MTT assays. The effect of Hsp90 expression on the drug resistance to Cisplatin in two Cell Lines was analyzed. RESULTS: Compared with the respective control cells, Hsp90 expressions in both experimental cell lines were up-regulated obviously, exhibiting a dose-dependent manner to GGA. MTT assays revealed that the IC(50)s of cisplatin also showed a substantial elevation for the experimental cells of SPCA-1 and H446, and this elevation was also associated with GGA concerntration. CONCLUSION: GGA is effective for the induction of Hsp90 in the SPCA-1 and H446 cell line. Up-regulated Hsp90 is associated with the chemoresistance to Cisplatin in SPCA-1and H446 cells. 中国肺癌杂志编辑部 2011-06-20 /pmc/articles/PMC5999893/ /pubmed/21645448 http://dx.doi.org/10.3779/j.issn.1009-3419.2011.06.02 Text en 版权所有©《中国肺癌杂志》编辑部2011 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle 基础研究
Hsp90表达上调与肺癌细胞化疗耐药的相关性研究
title Hsp90表达上调与肺癌细胞化疗耐药的相关性研究
title_full Hsp90表达上调与肺癌细胞化疗耐药的相关性研究
title_fullStr Hsp90表达上调与肺癌细胞化疗耐药的相关性研究
title_full_unstemmed Hsp90表达上调与肺癌细胞化疗耐药的相关性研究
title_short Hsp90表达上调与肺癌细胞化疗耐药的相关性研究
title_sort hsp90表达上调与肺癌细胞化疗耐药的相关性研究
topic 基础研究
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999893/
https://www.ncbi.nlm.nih.gov/pubmed/21645448
http://dx.doi.org/10.3779/j.issn.1009-3419.2011.06.02
work_keys_str_mv AT hsp90biǎodáshàngdiàoyǔfèiáixìbāohuàliáonàiyàodexiāngguānxìngyánjiū
AT hsp90biǎodáshàngdiàoyǔfèiáixìbāohuàliáonàiyàodexiāngguānxìngyánjiū
AT hsp90biǎodáshàngdiàoyǔfèiáixìbāohuàliáonàiyàodexiāngguānxìngyánjiū